Dianthus Therapeutics Inc.
DNTH | NASDAQ
$98.85
+$2.38 (+2.47%)
Sep 22, 2026, 1:18 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.9M | 1.34M | 2.04M | 3.08M | 4.85M | 6.52M | 6.24M | 5.37M | 4.12M | 3.22M | 2.83M | 3.54M | 3.79M | 2.82M | 2.35M | 1.17M | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 76K | 76K | n/a | n/a | n/a | n/a | n/a | n/a | 19K | 103K | 103K | 152K | 133K | 1.25M | 2.46M | 2.94M | 3.47M | 2.76M | 1.55M | 1.01M | 479K | n/a |
Gross Profit | 1.83M | 1.26M | 2.04M | 3.08M | 4.85M | 6.52M | 6.24M | 5.37M | 4.1M | 3.12M | 2.72M | 3.39M | 3.66M | 1.58M | -107K | -1.77M | -3.47M | -2.76M | -1.55M | -1.01M | -479K | n/a |
Operating Income | -217.84M | -191.29M | -177.93M | -140.31M | -129.92M | -117.2M | -101.86M | -82.9M | -68.76M | -58.34M | -48.17M | -45.91M | -38.41M | -44.71M | -60.86M | -70.31M | -80.3M | -79.83M | -74.69M | -73.62M | -73.75M | -76.16M |
Interest Income | 26.73M | 18.59M | 16.12M | 14.84M | 15.63M | 16.93M | 17.37M | 15.82M | 12.4M | 8.38M | 4.76M | 2.96M | 2.35M | 2.47M | 2.75M | 2.11M | 1.8M | 1.08M | 1.41M | 2.31M | 2.91M | 3.74M |
Pretax Income | -29.91M | -11.32M | n/a | -126.35M | -114.75M | -100.73M | -84.97M | -67.09M | -56.68M | -50.21M | -43.56M | -43.11M | -36.13M | -42.26M | -58.12M | -67.3M | -76.94M | -76.6M | -71.14M | -70.01M | -70.26M | -72.41M |
Net Income | -29.91M | -11.32M | n/a | -126.35M | -114.75M | -100.73M | -84.97M | -67.09M | -56.68M | -50.21M | -43.56M | -43.11M | -36.13M | -42.26M | -58.12M | -67.3M | -76.94M | -76.6M | -71.14M | -70.01M | -70.26M | -72.41M |
Selling & General & Admin | 44.15M | 39.46M | 34.33M | 31.23M | 29.56M | 26.69M | 24.99M | 22.8M | 24.97M | 21.38M | 18.06M | 15.41M | 8.92M | 12.99M | 17.96M | 23M | 28.24M | 28.24M | 27.93M | 27.71M | 26.85M | 27.78M |
Research & Development | 175.6M | 153.16M | 145.64M | 112.16M | 105.21M | 97.03M | 83.11M | 65.47M | 47.89M | 40.07M | 32.84M | 33.89M | 33.15M | 33.3M | 42.79M | 45.54M | 48.59M | 48.83M | 45.22M | 44.9M | 46.42M | 48.38M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 219.67M | 192.55M | 179.97M | 143.39M | 134.77M | 123.72M | 108.1M | 88.27M | 72.86M | 61.46M | 50.9M | 49.3M | 42.07M | 46.29M | 60.76M | 68.54M | 76.83M | 77.07M | 73.15M | 72.61M | 73.27M | 76.16M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 812K | 812K | 812K | 812K | n/a | 1.21M | 2.11M | 2.81M | 3.74M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 219.75M | 192.63M | 179.97M | 143.39M | 134.77M | 123.72M | 108.1M | 88.27M | 72.88M | 61.56M | 51M | 49.46M | 42.2M | 47.54M | 63.21M | 71.48M | 80.3M | 79.83M | 74.69M | 73.62M | 73.75M | 76.16M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 56.03M | 48.03M | 37.79M | 37.79M | 35.82M | 35.79M | 35.03M | 34.24M | 34.23M | 25.67M | 4.53M | 3.91M | 3.79M | 3.79M | 3.79M | 3.7M | 3.68M | 3.67M | 3.67M | 3.66M | 3.36M | 3.04M |
Shares Outstanding (Diluted) | 56.03M | 48.03M | 37.79M | 37.79M | 35.82M | 35.79M | 35.03M | 34.24M | 34.23M | 25.67M | 4.53M | 3.91M | 3.79M | 3.79M | 3.79M | 3.7M | 3.68M | 3.67M | 3.67M | 3.66M | 3.36M | 3.04M |
EPS (Basic) | -0.13 | -0.11 | -0.08 | -3.48 | -3.25 | -2.88 | -2.60 | -4.12 | -7.16 | -7.52 | -14.68 | -15.02 | -13.34 | -17.17 | -15.71 | -18.30 | -20.96 | -21.30 | -20.81 | -21.55 | -22.65 | -25.32 |
EPS (Diluted) | -0.13 | -0.11 | -0.08 | -3.48 | -3.25 | -2.88 | -2.60 | -4.12 | -7.16 | -7.52 | -14.68 | -15.02 | -13.34 | -17.17 | -15.71 | -18.30 | -20.96 | -21.30 | -20.81 | -21.55 | -22.65 | -25.32 |
EBITDA | -29.51M | -10.86M | 518K | -126.01M | -114.33M | -100.29M | -84.56M | -66.66M | -56.34M | -51.82M | -45.25M | -44.86M | -37.89M | -40.99M | -55.66M | -64.35M | -73.47M | -73.84M | -69.12M | -68.03M | -68.32M | -70.46M |
EBIT | -29.91M | -11.32M | n/a | -126.35M | -114.75M | -100.73M | -84.97M | -67.09M | -56.68M | -52.13M | -45.47M | -45.03M | -38.05M | -42.26M | -58.12M | -67.3M | -76.94M | -76.6M | -71.14M | -70.01M | -70.26M | -72.41M |
Depreciation & Amortization | 399K | 461K | 518K | 337K | 426K | 438K | 412K | 437K | 340K | 313K | 220K | 166K | 157K | 1.27M | 2.47M | 2.95M | 3.47M | 2.76M | 2.02M | 1.98M | 1.94M | 1.96M |
Add to Watchlist
Select watchlists to add or remove DNTH